Skip to main content
. 2020 Oct 5;10:16490. doi: 10.1038/s41598-020-73752-3

Figure 8.

Figure 8

Expression of Spred2 mRNA in the lung of WT mice before and after BLM treatment. Lungs were harvested from untreated WT mice (naïve) or 1, 7 or 14 days after the intratracheal instillation of BLM. (a) The expression of Spred2 mRNA was examined on day 0 (naïve), 1 and 7 after BLM treatment by ISH. Left panels: H&E staining. Middle panels: ISH. Right panels: The area indicated by a rectangle in the middle panel is further magnified. Almost all cells expressed a significant level of Spred2 mRNA (blue-green dots) in naive mice as indicated by arrows. By contrast, Spred2 mRNA was expressed at a low level on day 1 and 7 as indicated by an arrow. The magnification of the original photos was 400×. The scale bars are 50 μm. (b) The expression of Spred2 mRNA on day 14 was examined by ISH. Top left panel: H&E staining. Bottom left panel: The area indicated by a rectangle in the top left panel is further magnified. Top right panel: ISH. Bottom right panel: The area indicated by a rectangle in the top right panel is further magnified. Spred2 mRNA accumulated in approximately 50% of bronchial epithelial cells, likely Clara cells by morphology, as indicated by arrows. The magnification of the original photos was 400×. The scale bars are 50 μm.